Navigation Links
Heart Device Recipients Often Not Aware of Recalls
Date:5/15/2008

Some not clear on risks of problems, two surveys find

THURSDAY, May 15 (HealthDay News) -- Two new surveys suggest that many heart patients with implanted devices aren't aware of recent recalls and don't understand the dangers they might face.

The surveys are small, but they point to a lack of understanding among both doctors and patients about heart disease and the devices used to treat it, said Dr. Bruce Wilkoff, director of cardiac and tachyarrhythmia devices at Cleveland Clinic.

"There are fundamental problems with even the physician's understanding of the situation and an appropriate focus on accurate information," said Wilkoff, who is familiar with the surveys.

Recent recalls of implanted defibrillators have forced some patients to have them removed. The devices deliver jolts to the heart that reset its electrical system when needed.

One of the new surveys found that almost one in five heart patients didn't know about recent recalls of their devices.

The findings, expected to be released at the Heart Rhythm Society's annual meeting, in San Francisco, came in a survey of 61 randomly selected patients at the University of Maryland and the Baltimore VA Medical Center. They were asked about recalls between October 2006 and April 2007.

Eighteen percent didn't know about any pacemaker or defibrillator recall. About half learned about them through the media, and only 24 percent heard through their doctor.

More than half said they'd be very worried if their device was recalled.

"We need to do a little better of a job and find better means of talking to our patients," said survey lead author Dr. Timm-Michael Dickfeld, director of electrophysiology at the Baltimore VA Medical Center. "They seem to like to have the physicians talk to them more, and explain these things more, and not leave it up to the media or the TV to inform them."

A second survey, by doctors at the University of Oklahoma, asked 165 patients with a variety of heart devices whether they'd want them removed if there was a recall or safety advisory.

Just 5 percent said they'd want the device removed immediately if there was a "recall," and 2.5 percent said they'd want it taken out if there was a "safety advisory."

The patients gave a variety of answers when asked what they thought the chances were that they'd experience a device recall, with 31 percent thinking it was one in 100,000.

Dr. Andrea Russo, an electrophysiologist at the University of Pennsylvania, said the results of the Maryland survey suggest that officials should stop using the word "recall" in favor of "safety device."

"The term 'recall' implies that the device will fail dramatically and the failure will be potentially 'life-threatening,' with the term implying that it should be 'taken out,'" she said. The reality, according to her, may be different.

"The types of failures may vary dramatically, and the outcome following 'failure' is also quite variable and not necessarily life-threatening," she said.

More information

Learn more about implanted defibrillators from the American Heart Association.



SOURCES: Bruce Wilkoff, M.D., director, cardiac and tachyarrhythmia devices, Cleveland Clinic; Timm-Michael Dickfeld, M.D., Ph.D., director, electrophysiology, Baltimore VA Medical Center, and assistant professor, University of Maryland; Andrea Russo, M.D., electrophysiologist, University of Pennsylvania, Philadelphia; May 15, 2008, presentation, Heart Rhythm Society's annual meeting, San Francisco


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Weight-Loss Aids Bought on Internet Might Harm Your Heart
2. New Guidelines Issued for Implanted Heart Devices
3. The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines
4. Hidden heart condition increases the risk of death in patients waiting for kidney transplants
5. Biomarkers Predict Heart Deaths
6. Heart Disease Starts Early in Life
7. Danger From Heart Surgery Drug Confirmed
8. HeartWare to Present at Seventh Annual JMP Securities Research Conference
9. Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
10. Drug therapy for PKU reverses heart damage
11. Stater Bros. Raises $501,707 for American Heart Association
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Heart Device Recipients Often Not Aware of Recalls
(Date:4/25/2017)... ... April 25, 2017 , ... ... announces Mirroring360 Pro . This new addition to the Mirroring360 product family ... education and business. , Mirroring360 Pro enables educators, business professionals and individuals to ...
(Date:4/25/2017)... , ... April 25, 2017 , ... A stressful work ... work can also decrease overall productivity and performance in the workplace. The goal of ... During the last few weeks of April, Clearview Resolution Services will be shutting down ...
(Date:4/25/2017)... ... 25, 2017 , ... The doctors at Wall Centre Dental are now expanding ... and require sedation to receive dental care. The doctors offer three treatment options to ... cleanings to oral surgery, at their dental office in Vancouver. Wall Centre Dental is ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Buyers and sellers ... users to dispensaries and head shops –can’t help but be heartened by the industry’s ... tell-tale cannabis odor aptly described as “skunk smell.” At last they can simply, ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... 2017 Research and Markets has announced the ... to their offering. ... arthroscopy devices market to grow at a CAGR of 6.35% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
(Date:4/18/2017)... Research and Markets has announced the ... Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" report ... ... as well as growth in the number of unit shipments ... market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology: